More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

Jared Holz, Mizuho Healthcare Sector strategist, joins 'Closing Bell Overtime' to talk Moderna and Novo Nordisk.

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and considered life-saving.

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Japan began administering new COVID-19 shots on Sept ... can be administered to people 12 and older, while Moderna Inc.’s Omicron booster is authorized for those 18 and older.

Moderna submitted data to the Food and Drug ... The side effects from the booster shots appear to be similar to those from the original series in this age group as well as in adults, Dr. Steven ...

One dose of the Novovax (as well as Moderna or Pfizer) also is acceptable for ages 12 through 64, unless you've never had the vaccine and choose Novovax because two doses will be needed. For people ...

"It does not matter whether or not you got an earlier version of the vaccine be it the primary series, booster ... Pfizer and Moderna have priced their updated COVID vaccines at about $125.

The 75% protection against Covid symptoms after a booster is not as high as against previous variants. There was not enough data to analyse the Moderna or Janssen vaccines, but there is no reason ...

The order of the bivalent shot follows the announcement last month that the federal government had secured 105 million doses of a similar vaccine from rival drugmaker Pfizer. Both orders are scheduled ...